PLoS ONE 10 , e0141921 (2015)
Since CV outcomes occur irrespective of glycemic control, patients and providers should be encouraged to continue well-tolerated, guideline-recommended GLP-1 RA therapy even when glycemic benefits are not as evident
(1) Glutathione and Schizophrenia Quoting Lorraine Wilder (whose MSc in schizophrenia we funded) Glutathione (GSH) is an important antioxidant and free radical scavenger that has been found to be decreased in the brains of people with schizophrenia [2, 3]
Patients Planning Surgery If you have an upcoming surgery that requires general anesthesia, inform both your prescribing provider and your surgical team
Am J Clin Nutr 89:2025S-2039S
Clinical trials Although several studies using in vitro and in vivo experimental models have reported the protective effects of polyphenols in CFS and muscle atrophies, human use is still scarce in this area, perhaps due to ambiguities in polyphenol bioavailability, doses, and lack of efficacy in humans (Nikawa et al
